{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:31:34Z","timestamp":1772688694231,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH038"],"award-info":[{"award-number":["ZR2021MH038"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR202108090005"],"award-info":[{"award-number":["ZR202108090005"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Affiliated Hospital of Qingdao University \u201cClinical Medicine+X\u201d Scientific Research Project","award":["QDFY+X202101013"],"award-info":[{"award-number":["QDFY+X202101013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI radiopharm. chem."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to prepare a novel <jats:sup>68<\/jats:sup>Ga-labeled pH (low) insertion peptide (pHLIP)-like peptide, YJL-4, and determine its value for the early diagnosis of triple-negative breast cancer (TNBC) via in vivo imaging of tumor-bearing nude mice. The novel peptide YJL-4 was designed using a template-assisted method and synthesized by solid-phase peptide synthesis. After modification with the chelator 1,4,7\u2011triazacyclononane-N,N\u2032,N\u2033-triacetic acid (NOTA), the peptide was labeled with <jats:sup>68<\/jats:sup>Ga. Then, the biodistribution of <jats:sup>68<\/jats:sup>Ga-YJL-4 in tumor-bearing nude mice was investigated, and the mice were imaged by small animal positron emission tomography (PET).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The radiochemical yield and radiochemical purity of <jats:sup>68<\/jats:sup>Ga-YJL-4 were 89.5\u2009\u00b1\u20090.16% and 97.95\u2009\u00b1\u20090.06%, respectively. The biodistribution of <jats:sup>68<\/jats:sup>Ga-YJL-4 in tumors (5.94\u2009\u00b1\u20091.27% ID\/g, 6.72\u2009\u00b1\u20091.69% ID\/g and 4.54\u2009\u00b1\u20090.58% ID\/g at 1, 2 and 4\u00a0h after injection, respectively) was significantly greater than that of the control peptide in tumors at the corresponding time points (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Of the measured off-target organs, <jats:sup>68<\/jats:sup>Ga-YJL-4 was highly distributed in the liver and blood. The small animal PET imaging results were consistent with the biodistribution results. The tumors were visualized by PET at 2 and 4\u00a0h after the injection of <jats:sup>68<\/jats:sup>Ga-YJL-4. No tumors were observed in the control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The novel pHLIP family peptide YJL-4 can adopt an <jats:italic>\u03b1-<\/jats:italic>helical structure for easy insertion into the cell membrane in an acidic environment. <jats:sup>68<\/jats:sup>Ga-YJL-4 was produced in high radiochemical yield with good stability and can target TNBC tissue. Moreover, the strong concentration of radioactive <jats:sup>68<\/jats:sup>Ga-YJL-4 in the abdomen does not hinder the imaging of early TNBC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41181-024-00267-x","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T17:02:29Z","timestamp":1714237349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Small animal PET imaging with the 68Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model"],"prefix":"10.1186","volume":"9","author":[{"given":"YueHua","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ShuangShuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YanQin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FengYu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GuangJie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhenGuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-005X","authenticated-orcid":false,"given":"MingMing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,27]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","DOI":"10.1021\/mp5002526","author":"RC Adochite","year":"2014","unstructured":"Adochite RC, Moshnikova A, Carlin SD, Guerrieri RA, Andreev OA, Lewis JS, et al. Targeting breast tumors with pH (low) insertion peptides. Mol Pharm. 2014. https:\/\/doi.org\/10.1021\/mp5002526.","journal-title":"Mol Pharm"},{"key":"267_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903986","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med. 2019. https:\/\/doi.org\/10.1056\/NEJMoa1903986.","journal-title":"N Engl J Med"},{"key":"267_CR3","doi-asserted-by":"publisher","DOI":"10.1055\/a-1307-1923","author":"YH Chen","year":"2021","unstructured":"Chen YH, Yu MM, Wang ZG. Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP. Nuklearmedizin. 2021. https:\/\/doi.org\/10.1055\/a-1307-1923.","journal-title":"Nuklearmedizin"},{"key":"267_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.869260","author":"Y Chen","year":"2022","unstructured":"Chen Y, Su Y, Pang X, Song X, Zhao W, Yu M. Synthesis and evaluation of technetium-99m-labeled pH (low) insertion peptide variant 7 for early diagnosis of MDA-MB-231 triple-negative breast cancer by targeting the tumor microenvironment. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.869260.","journal-title":"Front Oncol"},{"key":"267_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134537","author":"D de Jong","year":"2023","unstructured":"de Jong D, Desperito E, Al Feghali KA, Dercle L, Seban RD, Das JP, et al. Advances in PET\/CT imaging for breast cancer. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12134537.","journal-title":"J Clin Med"},{"key":"267_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01143","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO, Garc\u00eda-Carranc\u00e1 A, Manzo-Merino J. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol. 2019. https:\/\/doi.org\/10.3389\/fonc.2019.01143.","journal-title":"Front Oncol"},{"key":"267_CR7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.6b00306","author":"DW Demoin","year":"2016","unstructured":"Demoin DW, Wyatt LC, Edwards KJ, Abdel-Atti D, Sarparanta M, Pourat J, et al. PET Imaging of extracellular pH in tumors with (64)Cu- and (18)F-labeled pHLIP peptides: a structure-activity optimization study. Bioconjug Chem. 2016. https:\/\/doi.org\/10.1021\/acs.bioconjchem.6b00306.","journal-title":"Bioconjug Chem"},{"key":"267_CR8","doi-asserted-by":"publisher","DOI":"10.1159\/000516419","author":"N Ditsch","year":"2021","unstructured":"Ditsch N, Kolberg-Liedtke C, Friedrich M, Jackisch C, Albert US, Banys-Paluchowski M, et al. AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2021. Breast Care (basel). 2021. https:\/\/doi.org\/10.1159\/000516419.","journal-title":"Breast Care (basel)"},{"key":"267_CR9","doi-asserted-by":"publisher","DOI":"10.1021\/bc300348d","author":"CL Ferreira","year":"2012","unstructured":"Ferreira CL, Yapp DT, Mandel D, Gill RK, Boros E, Wong MQ, et al. (68) Ga small peptide imaging: comparison of NOTA and PCTA. Bioconjug Chem. 2012. https:\/\/doi.org\/10.1021\/bc300348d.","journal-title":"Bioconjug Chem"},{"key":"267_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nano8110884","author":"K Greish","year":"2018","unstructured":"Greish K, Pittal\u00e0 V, Taurin S, Taha S, Bahman F, Mathur A, et al. Curcumin-copper complex nanoparticles for the management of triple-negative breast cancer. Nanomaterials (basel). 2018. https:\/\/doi.org\/10.3390\/nano8110884.","journal-title":"Nanomaterials (basel)"},{"key":"267_CR11","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.7b01371","author":"C Gupta","year":"2017","unstructured":"Gupta C, Mertz B. Protonation enhances the inherent helix-forming propensity of pHLIP. ACS Omega. 2017. https:\/\/doi.org\/10.1021\/acsomega.7b01371.","journal-title":"ACS Omega"},{"key":"267_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2018.11.002","author":"C Gupta","year":"2018","unstructured":"Gupta C, Ren Y, Mertz B. Cooperative nonbonded forces control membrane binding of the pH-Low insertion peptide pHLIP. Biophys J. 2018. https:\/\/doi.org\/10.1016\/j.bpj.2018.11.002.","journal-title":"Biophys J"},{"key":"267_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-019-09884-9","author":"MJ Haney","year":"2020","unstructured":"Haney MJ, Zhao Y, Jin YS, Li SM, Bago JR, Klyachko NL, et al. Macrophage-derived extracellular vesicles as drug delivery systems for triple negative breast cancer (TNBC) therapy. J Neuroimmune Pharmacol. 2020. https:\/\/doi.org\/10.1007\/s11481-019-09884-9.","journal-title":"J Neuroimmune Pharmacol"},{"key":"267_CR14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16938","author":"AA Jitariu","year":"2017","unstructured":"Jitariu AA, C\u00eempean AM, Ribatti D, Raica M. Triple negative breast cancer: the kiss of death. Oncotarget. 2017. https:\/\/doi.org\/10.18632\/oncotarget.16938.","journal-title":"Oncotarget"},{"key":"267_CR15","doi-asserted-by":"publisher","DOI":"10.33218\/prnano1(3).181029.1","author":"AE Krausz","year":"2018","unstructured":"Krausz AE, Adler BL, Makdisi J, Schairer D, Rosen J, Landriscina A, et al. Nanoparticle-encapsulated doxorubicin demonstrates superior tumor cell kill in triple negative breast cancer subtypes intrinsically resistant to doxorubicin. Precis Nanomed. 2018. https:\/\/doi.org\/10.33218\/prnano1(3).181029.1.","journal-title":"Precis Nanomed"},{"key":"267_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(04)86001-4","author":"AP Pathak","year":"2004","unstructured":"Pathak AP, Gimi B, Glunde K, Ackerstaff E, Artemov D, Bhujwalla ZM. Molecular and functional imaging of cancer: advances in MRI and MRS. Methods Enzymol. 2004. https:\/\/doi.org\/10.1016\/S0076-6879(04)86001-4.","journal-title":"Methods Enzymol"},{"key":"267_CR17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.043349","author":"MF Penet","year":"2008","unstructured":"Penet MF, Glunde K, Jacobs MA, Pathak AP, Bhujwalla ZM. Molecular and functional MRI of the tumor microenvironment. J Nucl Med. 2008. https:\/\/doi.org\/10.2967\/jnumed.107.043349.","journal-title":"J Nucl Med"},{"key":"267_CR18","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.107.109967","author":"YK Reshetnyak","year":"2007","unstructured":"Reshetnyak YK, Segala M, Andreev OA, Engelman DM. A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. Biophys J. 2007. https:\/\/doi.org\/10.1529\/biophysj.107.109967.","journal-title":"Biophys J"},{"key":"267_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804746105","author":"YK Reshetnyak","year":"2008","unstructured":"Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Acad Sci USA. 2008. https:\/\/doi.org\/10.1073\/pnas.0804746105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv298","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015. https:\/\/doi.org\/10.1093\/annonc\/mdv298.","journal-title":"Ann Oncol"},{"key":"267_CR21","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"267_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.04.006","author":"A Sorolla","year":"2019","unstructured":"Sorolla A, Wang E, Clemons TD, Evans CW, Plani-Lam JH, Golden E, et al. Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides. Nanomedicine. 2019. https:\/\/doi.org\/10.1016\/j.nano.2019.04.006.","journal-title":"Nanomedicine"},{"key":"267_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220038110","author":"EA Sosunov","year":"2013","unstructured":"Sosunov EA, Anyukhovsky EP, Sosunov AA, Moshnikova A, Wijesinghe D, Engelman DM, et al. pH (low) insertion peptide (pHLIP) targets ischemic myocardium. Proc Natl Acad Sci U S A. 2013. https:\/\/doi.org\/10.1073\/pnas.1220038110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"267_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0282(2000)55:1<4::AID-BIP30>3.0.CO;2-M","author":"A Tossi","year":"2000","unstructured":"Tossi A, Sandri L, Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers. 2000. https:\/\/doi.org\/10.1002\/1097-0282(2000)55:1%3c4::AID-BIP30%3e3.0.CO;2-M.","journal-title":"Biopolymers"},{"key":"267_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/bi00013a031","author":"EM Tytler","year":"1995","unstructured":"Tytler EM, Anantharamaiah GM, Walker DE, Mishra VK, Palgunachari MN, Segrest JP. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry. 1995. https:\/\/doi.org\/10.1021\/bi00013a031.","journal-title":"Biochemistry"},{"key":"267_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3402-9","author":"GA Ulaner","year":"2016","unstructured":"Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, et al. (18)F-FDG-PET\/CT for systemic staging of newly diagnosed triple-negative breast cancer. Eur J Nucl Med Mol Imaging. 2016. https:\/\/doi.org\/10.1007\/s00259-016-3402-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"267_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.36685","author":"DM Valcourt","year":"2019","unstructured":"Valcourt DM, Dang MN, Day ES. IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer. J Biomed Mater Res A. 2019. https:\/\/doi.org\/10.1002\/jbm.a.36685.","journal-title":"J Biomed Mater Res A"},{"key":"267_CR28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303708110","author":"D Weerakkody","year":"2013","unstructured":"Weerakkody D, Moshnikova A, Thakur MS, Moshnikova V, Daniels J, Engelman DM, et al. Family of pH (low) insertion peptides for tumor targeting. Proc Natl Acad Sci USA. 2013. https:\/\/doi.org\/10.1073\/pnas.1303708110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"267_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-021-01702-0","author":"F Wu","year":"2022","unstructured":"Wu F, Chen Y, Li D, Wang Z, Yu M. Synthesis and evaluation of radioiodine-labeled pH (low) insertion peptide variant 7-like peptide as a noninvasive tumor microenvironment imaging agent in a mouse MDA-MB-231 triple-negative breast cancer model. Mol Imaging Biol. 2022. https:\/\/doi.org\/10.1007\/s11307-021-01702-0.","journal-title":"Mol Imaging Biol"},{"key":"267_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715350115","author":"LC Wyatt","year":"2018","unstructured":"Wyatt LC, Moshnikova A, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors. Proc Natl Acad Sci U S A. 2018. https:\/\/doi.org\/10.1073\/pnas.1715350115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"267_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05560-2","author":"M Yu","year":"2020","unstructured":"Yu M, Chen Y, Wang Z, Ding X. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1. Breast Cancer Res Treat. 2020. https:\/\/doi.org\/10.1007\/s10549-020-05560-2.","journal-title":"Breast Cancer Res Treat"},{"key":"267_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5565932","author":"M Yu","year":"2021","unstructured":"Yu M, Sun Y, Yang G, Wang Z. An experimental study on [125I]I-pHLIP (Var7) for SPECT\/CT imaging of an MDA-MB-231 triple-negative breast cancer mouse model by targeting the tumor microenvironment. Mol Imaging. 2021. https:\/\/doi.org\/10.1155\/2021\/5565932.","journal-title":"Mol Imaging"},{"key":"267_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3558-1","author":"Y Yue","year":"2015","unstructured":"Yue Y, Cui X, Bose S, Audeh W, Zhang X, Fraass B. Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET\/CT imaging. Breast Cancer Res Treat. 2015. https:\/\/doi.org\/10.1007\/s10549-015-3558-1.","journal-title":"Breast Cancer Res Treat"}],"container-title":["EJNMMI Radiopharmacy and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-024-00267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41181-024-00267-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41181-024-00267-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T17:02:35Z","timestamp":1714237355000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmipharmchem.springeropen.com\/articles\/10.1186\/s41181-024-00267-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1186\/s41181-024-00267-x","relation":{},"ISSN":["2365-421X"],"issn-type":[{"value":"2365-421X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no existing financial conflicts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}